Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

Q: Recently, a 47-year-old asymptomatic patient had a random prostate-specific antigen (PSA) level of 5.32 ng/mL. A repeat assay the following day was 6.10. All previous PSAs over a seven-year period ...

Because the etiology of chronic nonbacterial prostatitis is unknown, a variety of treatments have been proposed. The best-designed, largest clinical trials have not found the most commonly used ...